Gainers
- Palisade Bio (NASDAQ:PALI) shares increased by 111.8% to $6.82 during Friday's regular session. The current volume of 67.8 million shares is 4351.8% of Palisade Bio's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $9.7 million.
- Dermata Therapeutics (NASDAQ:DRMA) shares increased by 80.34% to $0.36. As of 12:30 EST, this security is trading at a volume of 37.6 million shares, making up 4522.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.3 million.
- F-star Therapeutics (NASDAQ:FSTX) stock moved upwards by 45.96% to $5.97. As of 12:30 EST, F-star Therapeutics's stock is trading at a volume of 2.9 million, which is 934.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $131.2 million.
- 180 Life Sciences (NASDAQ:ATNF) shares increased by 37.33% to $2.6. Trading volume for 180 Life Sciences's stock is 16.8 million as of 12:30 EST. This is 1149.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.7 million.
- Kala Pharmaceuticals (NASDAQ:KALA) stock rose 35.86% to $33.75. Trading volume for this security as of 12:30 EST is 11.2 million, which is 765.9% of its average full-day volume over the last 100 days. The company's market cap stands at $53.8 million.
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.05% to $1.57. Salarius Pharmaceuticals's stock is trading at a volume of 240.1K shares as of 12:30 EST. This is 478.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.5 million.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Losers
- Hoth Therapeutics (NASDAQ:HOTH) shares fell 25.4% to $8.0 during Friday's regular session. Trading volume for Hoth Therapeutics's stock is 4.7 million as of 12:30 EST. This is 798.3% of its average full-day volume over the last 100 days. The company's market cap stands at $10.4 million.
- Nuwellis (NASDAQ:NUWE) stock fell 16.92% to $10.07. As of 12:30 EST, Nuwellis's stock is trading at a volume of 405.9K, which is 184.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.1 million.
- Revelation Biosciences (NASDAQ:REVBU) shares declined by 16.67% to $0.2.
- Reshape Lifesciences (NASDAQ:RSLS) shares decreased by 16.28% to $6.43. Reshape Lifesciences's stock is trading at a volume of 81.1K shares as of 12:30 EST. This is 285.1% of its average full-day volume over the last 100 days. The company's market cap stands at $3.1 million.
- Summit Therapeutics (NASDAQ:SMMT) shares fell 13.38% to $4.6. As of 12:30 EST, this security is trading at a volume of 3.1 million shares, making up 37.6% of its average full-day volume over the last 100 days. The company's market cap stands at $926.0 million.
- Femasys (NASDAQ:FEMY) stock fell 13.15% to $0.72. The market value of their outstanding shares is at $8.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.